期刊
JOURNAL OF IMMUNOLOGY
卷 210, 期 10, 页码 1519-1530出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.2200221
关键词
-
类别
Adjuvants are important additions to vaccines that enhance immune responses. Combining adjuvants can increase the efficacy of vaccines. In this study, the combination of dmLT and MPL-A showed enhanced immune responses and activation of dendritic cells.
Adjuvants are often essential additions to vaccines that enhance the activation of innate immune cells, leading to more potent and protective T and B cell responses. Only a few vaccine adjuvants are currently used in approved vaccine formulations in the United States. Combinations of one or more adjuvants have the potential to increase the efficacy of existing and next-generation vaccines. In this study, we investigated how the nontoxic double mutant Escherichia coli heat-labile toxin R192G/L211A (dmLT), when combined with the TLR4 agonist monophosphoryl lipid A (MPL-A), impacted innate and adaptive immune responses to vaccination in mice. We found that the combination of dmLT and MPL-A induced an expansion of Ag-specific, multifaceted Th1/2/17 CD4 T cells higher than that explained by adding responses to either adjuvant alone. Furthermore, we observed more robust activation of primary mouse bone marrow -derived dendritic cells in the combination adjuvant -treated group via engagement of the canonical NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome complex. This was marked by a multiplicative increase in the secretion of active IL-1b that was independent of classical gasdermin D -mediated pyroptosis. Moreover, the combination adjuvant increased the production of the secondary messengers cAMP and PGE2 in dendritic cells. These results demonstrate how certain adjuvant combinations could be used to potentiate better vaccine responses to combat a variety of pathogens. The Journal of Immunology, 2023,210: 1519-1530.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据